Dual Antiplatelet Therapy in Secondary Prevention of Ischemic Stroke: A Ghost from the Past or a New Frontier?

With majority of ischemic strokes attributable to atherothrombosis and many being predictable after transient ischemic attacks (TIA), the role of early secondary prevention with antiplatelet agents is under renewed investigation. Prior major clinical trials of various secondary stroke prevention reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Balucani, Clotilde, Barlinn, Kristian, Zivanovic, Zeljko, Parnetti, Lucilla, Silvestrini, Mauro, Alexandrov, Andrei V.
Formato: Texto
Lenguaje:English
Publicado: SAGE-Hindawi Access to Research 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018624/
https://www.ncbi.nlm.nih.gov/pubmed/21234304
http://dx.doi.org/10.4061/2010/427418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018624/
https://www.ncbi.nlm.nih.gov/pubmed/21234304
http://dx.doi.org/10.4061/2010/427418

Ejemplares similares